1. Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells
    Kyosuke Mukae et al, 2023, Cancer Science CrossRef
  2. Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma
    Keita Sasa et al, 2022, Technology in Cancer Research & Treatment CrossRef
  3. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
    Marina Ferreira Candido et al, 2023, Pharmaceutics CrossRef
  4. Dual responsive hydroxyapatite capped mesoporous silica nanoparticles for controlled delivery of Palbociclib to treat osteosarcoma
    Seyed Reza Heydari et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
  5. The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review
    Victoria L. Tippett et al, 2023, Oncogene CrossRef
  6. Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours
    Nil A. Schubert et al, 2022, European Journal of Cancer CrossRef
  7. NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression
    Qizhi Qin et al, 2022, Cancer Research CrossRef
  8. Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes
    Si-Yang Liu et al, 2021, Nature Communications CrossRef
  9. Combination of Genomic Landsscape and 3D Culture Functional Assays Bridges Sarcoma Phenotype to Target and Immunotherapy
    Filomena de Nigris et al, 2023, Cells CrossRef